Longevity.haus
FeM Surgery logo

FeM Surgery

Singapore, Singapore 2 treatments

About

FeM Surgery is a leading multidisciplinary surgical group practice in Singapore with six clinic locations spanning Orchard, Gleneagles, Novena, Alvernia, Farrer Park, and Clarke Quay. The practice brings together specialist surgeons across more than a dozen sub-specialties — from colorectal and endocrine surgery to urology and vascular medicine — supported by a dedicated Wellness Centre offering preventive and metabolic health services. Their Weight Management Clinic provides medically supervised programmes anchored in GLP-1 receptor agonist therapy, including semaglutide (Wegovy) and tirzepatide (Mounjaro), both HSA-approved treatments shown to achieve 10–20% body weight reduction over a 6–18 month treatment course. Each patient undergoes a thorough initial clinical consultation, baseline blood tests, and receives a personalised treatment plan with regular follow-up monitoring, dose titration support, and lifestyle guidance covering nutrition and exercise. The surgical backbone of the practice means patients with complex obesity-related conditions benefit from direct access to specialist review if escalation is required. FeM Surgery is committed to evidence-based, sustainable weight management — not quick fixes — positioning the clinic for patients seeking structured, long-term medical oversight for chronic weight challenges. The Wellness Centre also offers broader health screening services, integrating preventive care with specialist surgical expertise under one roof.
Price range
$250.00–$600.00
Treatments
2
Locations
1

Treatments

2 treatments

weight-management

Medical Weight Management Consultation

A specialist-led medical weight management consultation at FeM Surgery evaluates your weight history, metabolic health, and suitability for supervised treatment. The programme combines clinical oversight with lifestyle coaching for sustainable, long-term results.

$250.00

metabolic-glp1

GLP-1 Weight Loss Programme (Wegovy / Mounjaro)

FeM Surgery's GLP-1 weight loss programme uses HSA-approved semaglutide (Wegovy) or tirzepatide (Mounjaro) under specialist medical supervision, delivering clinically proven 10–20% body weight reduction over 6–18 months with ongoing dose titration and lifestyle support.

$600.00

Locations

1 location

Frequently Asked Questions about FeM Surgery

FeM Surgery
2 treatments available